Pediatric brain tumor treatment at the University of Alabama awarded FDA grant for first-in-human study
On Dec. 17, 2019, the University of Alabama at Birmingham Comprehensive Cancer Center (UAB) announced that Gregory Friedman,…
-
-
NIH launched first US clinical trial of patient-derived stem cell therapy to replace dying cells in retina
On Dec. 16, 2019, researchers at the National Eye Institute launched a clinical trial to test the safety…
-
Oregonian received life-saving heart valve repair without open-heart surgery
On Dec. 11, 2019, Dennis Eggers became the first patient in a new clinical trial to receive a…
-
The Masonic Cancer Center and the University of Minnesota opened a first-in-human clinical trial for treatment of advanced solid tumors
On Oct. 2, 2019, the Masonic Cancer Center and the University of Minnesota (UM) opened a new first-in-human…
-
Siteman Cancer Center awarded $7.8 million to expand clinical trials access
On Aug. 1, 2019 the Siteman Cancer Center announced it was awarded a six-year, $7.8 million grant from…
-
CanSinoBIO received approval for Its 13-valent penumococcal conjugate vaccine to start clinical trials
On Jun. 20, 2019, CanSino Biologics announced that it had received the National Medical Products Administration’s (NMPA) permission…
-
Karmanos Cancer Institute and Wayne State University awarded prestigious LAPS grant
On Dec. 20, 2018, the Karmanos Cancer Institute and Wayne State University were awarded the prestigious LAPS Grant…
-
Biotechnology | Disease | Genomics | Oncology | Therapeutics
The UK announced sequencing 100,000 whole genomes in the National Health Service
On Dec. 5, 2018, Genomics England announced the 100,000 Genomes Project, done in partnership with National Health Service…
-
ReFRAME drug repurposing collection yields hope for treating diseases that kill millions worldwide
On Oct. 3, 2018, Scripps Research announced that Calibr scientitsts from Scripp’s drug development division had begun using…
-
Biotechnology | Diagnostics | Disease | Oncology | Radiology | Therapeutics
National Cancer Institute scientists reported low-dose drug combination cuts risk of colon polyp recurrence
May 4, 2018, scientists from the National Cancer Institute (NCI) reported that an analysis of a prevention clinical…
-
University of Washington surgeons performed region’s 1st ‘liver in a box’ transplant
On Nov. 28, 2017, surgeons at University of Washinton Medicine in Seattle announced they had performed the first…
-
FDA licensed Shingrix, the new shingles vaccine from GlaxoSmithKline, for use in adults age 50 and older
On Oct. 23, 2017, GlaxoSmithKline announced the U.S. Food and Drug Administration (FDA) had approved Shingrix (Zoster Vaccine…
-
Siteman Cancer Center became one of the first cancer centers nationwide to offer newly approved CAR-T cell therapy called Yescarta
On Oct. 18, 2017, the Siteman Cancer Center became one of the first cancer centers nationwide to offer…
-
The University of Virginia Cancer Center received $15 million Renewal grant
On Apr. 26, 2017, the University of Virginia Cancer Center was honored as one of just 69 National…
-
Fred Hutch opened first-of-its kind Bezos Family Immunotherapy Clinic
On Nov. 1, 2016, the Fred Hutchinson Cancer Research Center announced the opening of the Bezos Family Immunotherapy…
-
Roswell Park study brought Cuban lung cancer vaccine to U.S. Patients
On Oct. 27, 2016, Roswell Park Cancer Institute announced it had received authorization from the U.S. Food and…
-
NIH announced final rule requirements for submitting clinical trial results information
On Sept. 21, 2016, the National Institutes of Health (NIH) announced final rule requirements for submitting registration and…
-
Bristol-Myers Squibb opened expanded biologics facility in Devens
On May 17, 2016, Bristol-Myers Squibb completed an expansion at its Devens, MA biologics facility designed to accelerate…
-
Benaroya Research Institute’s Carla J Greenbaum, MD was named chair of Type 1 Diabetes TrialNet
On Jul. 14, 2015, Benaroya Research Institute at Virginia Mason (BRI) announced that Carla J. Greenbaum, MD, had…
-
Rutgers Cancer Institute of New Jersey was one of seven worldwide sites to offer debulking prostatectomy
On May 5, 2015, Rutgers Cancer Institute of New Jersey was one of seven international sites to offer…
-
Benaroya Research Institute received 7-year award to lead Immune Tolerance Network
On Jan. 23, 2014, the National Institutes of Health (NIH) awarded the Benaroya Research Institute at Virginia Mason…
-
The Connecticut Challenge Survivorship Clinic Opened at Yale Cancer Center
On Sept. 28, 2012, the Connecticut Challenge Survivorship Clinic opened at Yale Cancer Center providing — the first…
-
The UC San Diego Health System acquired the Nevada Cancer Institute
On Jan. 23, 2012, UC San Diego Health System announced it had received approval to acquire the Nevada…
-
Rock and Roll Hall of Fame inductee Alice Cooper played a benefit concert at OMRF
On Jun. 24, 2012, Rock and Roll Hall of Fame inductee Alice Cooper helped raise $675,500 for the…
-
Roskamp Institute selected for funding by European Commission for a large-scale clinical trial on Nilvadipine
On May 25, 2011, the Roskamp Institute and an international research consortium led by Trinity College Dublin, were…
-
The first preventative vaccine for HIV was developed at University of Western Ontario
On Dec. 20, 2011, the U.S. Food and Drug Administration (FDA) announced approval of the first and only…
-
Pacific Northwest Diabetes Research Institute began clinical trials on antioxidant drug treatments on volunteers from Madigan Army Medical
In 2011, the Pacific Northwest Diabetes Research Institute began clinical trials on antioxidant drug treatments on volunteers from…
-
FDA approved licensure of Menveo (Novartis), meningococcal conjugate vaccine
On Feb. 19, 2010, the U.S. Food and Drug Administration (FDA) announced it had licensed a quadrivalent meningococcal…
-
Thai HIV vaccine clinical trial results were published in the New England Journal of Medicine
On Dec. 3, 2009, the Thai HIV vaccine clinical trial results were published in the New England Journal…
-
Dr. Brian Druker honored with Lasker Award
On Sept. 16, 2009, Brian J. Druker, M.D.,whose research led to the development of Gleevec, the first targeted…
